Logo image of BRO.CA

BARKSDALE RESOURCES CORP (BRO.CA) Stock Fundamental Analysis

TSX-V:BRO - TSX Venture Exchange - CA06766T1075 - Common Stock - Currency: CAD

0.12  0 (0%)

Fundamental Rating

0

Overall BRO gets a fundamental rating of 0 out of 10. We evaluated BRO against 0 industry peers in the Unkown industry. BRO has a bad profitability rating. Also its financial health evaluation is rather negative. BRO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BRO has reported negative net income.
In the past year BRO has reported a negative cash flow from operations.
BRO had negative earnings in each of the past 5 years.
In the past 5 years BRO always reported negative operating cash flow.
BRO.CA Yearly Net Income VS EBIT VS OCF VS FCFBRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -14.05%
ROE -15.26%
ROIC N/A
ROA(3y)-15.27%
ROA(5y)-16.17%
ROE(3y)-17.28%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
BRO.CA Yearly ROA, ROE, ROICBRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

BRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRO.CA Yearly Profit, Operating, Gross MarginsBRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

BRO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BRO has been increased compared to 5 years ago.
The debt/assets ratio for BRO has been reduced compared to a year ago.
BRO.CA Yearly Shares OutstandingBRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BRO.CA Yearly Total Debt VS Total AssetsBRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BRO has an Altman-Z score of 2.48. This is not the best score and indicates that BRO is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.06 indicates that BRO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACCN/A
WACCN/A
BRO.CA Yearly LT Debt VS Equity VS FCFBRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

BRO has a Current Ratio of 0.44. This is a bad value and indicates that BRO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.44 indicates that BRO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
BRO.CA Yearly Current Assets VS Current LiabilitesBRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.19% over the past year.
EPS 1Y (TTM)12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRO.CA Yearly Revenue VS EstimatesBRO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
BRO.CA Yearly EPS VS EstimatesBRO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03 -0.04

0

4. Valuation

4.1 Price/Earnings Ratio

BRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRO.CA Price Earnings VS Forward Price EarningsBRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRO.CA Per share dataBRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRO!.
Industry RankSector Rank
Dividend Yield N/A

BARKSDALE RESOURCES CORP

TSX-V:BRO (3/7/2025, 7:00:00 PM)

0.12

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-04 2025-03-04
Earnings (Next)07-28 2025-07-28
Inst Owners18.03%
Inst Owner ChangeN/A
Ins Owners3.26%
Ins Owner ChangeN/A
Market Cap16.27M
Analysts84.44
Price Target0.41 (241.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.05%
ROE -15.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.27%
ROA(5y)-16.17%
ROE(3y)-17.28%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34893.5%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z 2.48
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)15158.3%
Cap/Depr(5y)10897.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.24%
OCF growth 3YN/A
OCF growth 5YN/A